SUPN SUPERNUS PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1356576 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $17.49M 15 sales by 8 insiders
- Filings on record
- 279 since 2021-07-30, latest 2026-08-14 17:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Khattar Jack A. | Pres, CEO, Dir | — | $7.72M |
| Bhatt Padmanabh P. | CSO, SVP of IP | — | $5.42M |
| NEWHALL CHARLES W III | Dir | — | $1.27M |
| Mottola Frank | SVP, Chief Tech. Ops. Off | — | $1.10M |
| GEMAYEL GEORGES | Dir | — | $1.00M |
| Horich William Todd | SVP, Commercial Ops | — | $483.8K |
| Hudson Frederick M. | Dir | — | $271.7K |
| Sensenig Bethany | Dir | — | $228.3K |
| Rubin Jonathan | SVP, Chief Medical Off | — | — |
| Barlow Carrolee | Dir | — | — |
Transactions 317
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-10 | 2022-08-09 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +63.1K | 764.4K | +9% | $0 |
| D | 2022-08-10 | 2022-08-09 | SUPN | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $31.15 | -39.4K | 725.0K | -5% | -$1.23M |
| D | 2022-08-09 | 2022-08-08 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +192.0K | 819.2K | +31% | $0 |
| DM | 2022-08-09 | 2022-08-08 | SUPN | Khattar Jack A. | Pres, CEO, Dir | S - Sale+OE | $31.46 | -117.9K | 711.3K | -14% | -$3.71M |
| 2022-08-05 | 2022-07-15 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | A - Grant | $0.00 | +750 | 1,644 | +84% | $0 | |
| D | 2022-08-05 | 2022-08-04 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | S - Sale+OE | $32.98 | -5,000 | 87.2K | -5% | -$164.9K |
| D | 2022-08-05 | 2022-08-04 | SUPN | Martin Tami Tillotson | SVP, Regulatory Affairs | M - OptEx | $7.90 | +5,000 | 92.2K | +6% | +$39.5K |
| 2022-03-23 | 2022-03-18 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | +10.8K | 627.2K | +2% | — | |
| I | 2022-03-23 | 2022-03-18 | SUPN | Khattar Jack A. | Pres, CEO, Dir | J - Other | — | -10.8K | 1.05M | -1% | — |
| 2022-03-17 | 2022-03-14 | SUPN | Khattar Jack A. | Pres, CEO, Dir | A - Grant | $0.00 | +60.0K | 616.5K | +11% | $0 | |
| D | 2022-02-23 | 2022-02-19 | SUPN | Barlow Carrolee | Dir | A - Grant | $0.00 | +4,222 | 9,433 | +81% | $0 |
| D | 2022-02-23 | 2022-02-19 | SUPN | GEMAYEL GEORGES | Dir | A - Grant | $0.00 | +4,222 | 9,433 | +81% | $0 |
| D | 2022-02-23 | 2022-02-19 | SUPN | NEWHALL CHARLES W III | Dir | A - Grant | $0.00 | +4,222 | 101.7K | +4% | $0 |
| D | 2022-02-23 | 2022-02-19 | SUPN | SIEBERT JOHN M | Dir | A - Grant | $0.00 | +4,222 | 80.2K | +6% | $0 |
| D | 2022-02-23 | 2022-02-19 | SUPN | Hudson Frederick M. | Dir | A - Grant | $0.00 | +4,222 | 22.3K | +23% | $0 |
| D | 2021-08-12 | 2021-08-11 | SUPN | SIEBERT JOHN M | Dir | M - OptEx | $12.98 | +15.0K | 76.0K | +25% | +$194.7K |
| 2021-07-30 | 2021-07-30 | SUPN | Khattar Jack A. | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 556.5K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations